Applied DNA Sciences Revenue, Profits - APDN Annual Income Statement

Add to My Stocks
$1.15 $0 (0%) APDN stock closing price Aug 17, 2018 (Closing)

APDN stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Applied DNA Sciences stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 4.18M to 4.75M and how operating and non operating activities have impacted the APDN stock. Revenue for year 2017 is $4.75M and has increased from $4.18M year on year as is evident when you compare the latest figures in the latest Applied DNA Sciences profit and loss statement with those of the prior corresponding period. Also see Applied DNA Sciences assets and Applied DNA Sciences free cash flow for a complete valuation of APDN stock.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Oct - Sep2017201620152014201320122011201020092008
Applied DNA Sciences Revenues or Net Sales
Cost Of Goods Sold (COGS)1.07M---------
Applied DNA Sciences Gross Profit
Research & Development Expense2.28M3.69M1.63M1.3M------
Selling General & Admin Expense13.32M11.23M14.73M13.24M11.19M7.61M8.38M7.12M6.57M4.27M
Income Before Depreciation Depletion Amortization-11.93M-11.49M-7.36M-11.82M-9.85M-6.19M-7.68M-6.74M-6.47M-3.72M
Depreciation Depletion Amortization----------
Non Operating Income-0.03M--4M-0.78M-7.51M---12.02M-
Interest Expense------2.45M-1.18M2.64M
Applied DNA Sciences Pretax Income
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-12.85M-12.17M-11.88M-13.06M-17.68M-7.15M-10.51M-7.9M3.94M-6.8M
Extraordinary Items & Discontinued Operations----------
Applied DNA Sciences Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS26.38M23.69M18.94M13.52M11.75M9.62M6.29M5.02M5.16M-
Average Shares used to compute Basic EPS26.38M23.69M18.94M13.52M11.75M9.62M6.29M5.02M4.2M-
Income Before Nonrecurring Items-12.86M-12.18M-11.88M-13.07M-10.18M-7.15M-10.52M-7.91M3.95M-
Income from Nonrecurring Items-----7.51M-----
Applied DNA Sciences Earnings Per Share Basic Net
Applied DNA Sciences Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.49-0.51-0.63-0.97-1.20-0.60-1.80-1.800.60-
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Applied DNA Sciences stock analysis involves checking at least a few of the important things like:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Applied DNA Sciences revenue chart implies that the company is growing. It has been the case with Applied DNA Sciences. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-12.85M for Applied DNA Sciences for 2017. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The APDN financials along with Applied DNA Sciences historical stock prices provide a lot of details about the firm.

Applied DNA Sciences Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield